Inside UCSF takes a quick look at some of the biggest stories of 2013 that highlight the University and the campus community.
December 20, 2013
December 18, 2013
Research led by scientists at the UCSF-affiliated Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS. Further, they have identified an existing anti-inflammatory drug that in laboratory tests blocks the death of these cells.
December 18, 2013
A new study provides further proof that regular use of the the HIV antiretroviral drug Truvada can reduce one’s risk for contracting HIV – without increasing sexual risk behavior.
December 12, 2013
UC San Francisco’s Global Health Group has received a $15 million grant from the Bill & Melinda Gates Foundation for a pioneering effort to help nearly three dozen countries eliminate malaria within their borders.
December 03, 2013
Over more than two decades in Africa, UCSF researchers have approached their scientific work with a dual aim: treat disease while helping to sustainably build up the local health care system.
November 25, 2013
After heading the Obama administration’s global effort on AIDS, Eric Goosby is returning to his roots at UCSF to apply his experiences to improving public health programs.
November 21, 2013
UCSF Global Health Sciences and The Lancet Commission on Investing in Health invite the community to the San Francisco launch of a major new report: Global Health 2035: A World Converging within a Generation.
September 16, 2013
UCSF's fifth annual trauma summit, held at San Francisco General Hospital and Trauma Center, drew dozens of surgeons from developing countries who came to learn cutting-edge techniques.
August 22, 2013
The UCSF Global Health Sciences program celebrated its fifth Masters of Science graduating class earlier this month in a ceremony that also was a sendoff for the degree program’s founder.
June 04, 2013
In the search for clues on the global increase of asthma rates, Joshua Galanter, MD, is turning to the Olancho region of Honduras, an area with high rates of asthma compared to the rest of the world.